NWVCIL Logo
Medically Reviewed Content
Updated: July 2026
Sources: SAMHSA, NIDA

Suboxone Clinic Near You: Buprenorphine Treatment for Opioid Addiction

Find a Suboxone clinic near you. Buprenorphine — sold under brand names Suboxone, Sublocade, Subutex, Zubsolv, and Brixadi — is the most-prescribed MAT for opioid use disorder. It is a partial mu-opioid agonist with a ceiling effect that dramatically reduces overdose risk vs. methadone. After the MAT Act of 2023 eliminated the X-waiver requirement, any licensed prescriber can prescribe buprenorphine in office-based settings (OBOT), via telehealth, or at retail pharmacies. Buprenorphine is a Schedule III controlled substance and is covered by Medicaid in all 50 states.

Found 7,145 treatment centers offering buprenorphine (suboxone) across the United States.

Need Help Finding the Right Treatment Center?

Speak with a compassionate specialist now - 100% free & confidential

Call +1 (833) 244-3031
Available 24/7
All 50 States
Filters:

Showing 21 of 7145 results

CleanSlate Centers
Louisville, KY

CleanSlate Centers, located in Louisville, KY, provides outpatient services for substance use recovery, featuring programs that include methadone/buprenorphine and naltrexone therapies. The center employs techniques such as motivational interviewing, relapse prevention strategies, and counseling for substance use disorders to deliver personalized treatment for adults and young adults, regardless of gender. CleanSlate Centers is dedicated to creating customized care plans that assist individuals in their recovery paths. Their focus on delivering high-quality, specialized care positions them as an essential option for those looking for thorough addiction support in a nurturing setting.

CleanSlate Centers
Fort Wayne, IN

CleanSlate Centers in Fort Wayne, IN, provides outpatient care designed for adults and young adults facing substance use challenges. Their specialty lies in personalized treatment plans that incorporate motivational interviewing techniques, relapse prevention methods, and dedicated counseling for substance use disorders. The center offers medication-assisted treatment options, including methadone, buprenorphine, or naltrexone, to support recovery. CleanSlate Centers is committed to delivering high-quality support to both male and female individuals pursuing a path to lasting sobriety. For those desiring a tailored, research-backed recovery program, this location offers a promising solution.

CleanSlate Centers

CleanSlate Centers located in Kenosha, WI, provides outpatient services for substance use disorders aimed at both adults and young adults. This center focuses on outpatient treatments using methadone, buprenorphine, or naltrexone and employs motivational interviewing techniques, relapse prevention strategies, and counseling specific to substance use issues. Care at this facility is customized to meet the distinct requirements of each client, ensuring a personalized treatment experience. CleanSlate Centers prioritizes an individualized approach, serving both males and females in need of high-quality addiction rehabilitation. If you are in search of tailored, evidence-based support on your recovery path, this center is committed to assisting you in achieving enduring sobriety.

CleanSlate Centers

CleanSlate Centers, located in Phoenix, AZ, specializes in outpatient treatment programs for adults and young adults dealing with substance abuse. The center offers a variety of treatment options, including methadone, buprenorphine, and naltrexone, utilizing methods like motivational interviewing and strategies for preventing relapse, along with counseling for substance use disorders. Emphasizing personalized care, this facility serves both men and women looking for thorough rehabilitation services. CleanSlate Centers is dedicated to providing high-quality support, helping individuals on their path to recovery from substance use challenges.

CleanSlate Centers

CleanSlate Centers located in Gilbert, AZ, provides outpatient programs for substance use treatment designed for both adults and young adults. This center emphasizes outpatient therapies including methadone/buprenorphine and naltrexone, employing techniques such as motivational interviewing, strategies for preventing relapse, and counseling for substance use disorders. Focused on personalized treatment, the facility serves both men and women, creating a nurturing and thorough environment conducive to recovery. Their dedication to delivering high-quality and individualized care establishes CleanSlate Centers as an excellent option for individuals in the Gilbert region who are in need of effective and empathetic addiction treatment solutions.

CleanSlate Centers

CleanSlate Centers, located in Phoenix, Arizona, provides outpatient treatment options for substance use disorders, specifically focusing on methadone, buprenorphine, and naltrexone therapies. The center employs techniques such as motivational interviewing and relapse prevention alongside counseling tailored to substance abuse issues, ensuring that each program is customized to fit individual needs. Catering to adults and young adults across all genders, CleanSlate Centers in Phoenix fosters a welcoming and supportive atmosphere for those on their recovery journey. With a commitment to high-quality care and individualized treatment strategies, this center stands out as a reliable option for effective rehabilitation.

CleanSlate Centers

CleanSlate Centers located in Hyannis, MA, offers outpatient treatment for substance use disorders, featuring options such as methadone/buprenorphine and naltrexone. The center employs motivational interviewing techniques along with relapse prevention methods and counseling tailored to substance use issues, ensuring that care is customized for each person. Catering to adults and young adults of all genders, CleanSlate Centers emphasizes high-quality treatment combined with a focus on personalized care. If you or someone close to you is in search of effective addiction support that is comprehensive and individualized, this facility in Hyannis could be the right choice for you.

CleanSlate Centers
Indianapolis, IN

CleanSlate Centers located in Indianapolis, IN, specializes in outpatient treatment for substance use disorders, emphasizing personalized care for both adults and young adults. This facility offers outpatient options such as methadone/buprenorphine and naltrexone therapies, incorporating techniques like motivational interviewing, strategies for preventing relapse, and counseling specifically for substance use issues. The center adopts a customized approach to meet the distinct needs of each client and serves both men and women in need of thorough addiction rehabilitation. CleanSlate Centers in Indianapolis is dedicated to providing high-quality care and guidance to assist individuals in their recovery process.

CleanSlate Centers
Wilkes Barre, PA

CleanSlate Centers located in Wilkes Barre, PA, provides outpatient treatment for substance use disorders utilizing proven methods such as motivational interviewing, relapse prevention strategies, and counseling specific to substance use issues. This center offers outpatient services for methadone, buprenorphine, or naltrexone treatments, emphasizing a customized approach for both adult and young adult clients, regardless of gender. With a strong focus on delivering quality care, CleanSlate Centers develops treatment plans tailored to the distinct requirements of each individual. If you are looking for targeted substance use treatment that emphasizes personalized attention and effective therapeutic practices, this Wilkes Barre facility may be an excellent option for your recovery.

CleanSlate Centers
Williamsport, PA

CleanSlate Centers, located in Williamsport, PA, is a prominent outpatient facility dedicated to treating substance use disorders. This center provides outpatient services, including methadone/buprenorphine and naltrexone therapies, utilizing proven methods like motivational interviewing, relapse prevention strategies, and counseling for substance use issues. Committed to personalized care, it serves both adults and young adults across all gender identities. CleanSlate Centers fosters a nurturing atmosphere for individuals striving to conquer addiction, delivering exceptional care and tailored treatment strategies to support sustained recovery.

CleanSlate Centers
Bethlehem, PA

CleanSlate Centers, located in Bethlehem, PA, provides outpatient treatment services for adults and young adults dealing with substance use issues. The center specializes in outpatient therapies including methadone, buprenorphine, and naltrexone, emphasizing motivational interviewing, strategies for preventing relapse, and counseling for substance use disorders. Their personalized treatment plans are designed to meet the distinct needs of each individual. CleanSlate Centers features tailored programs for both men and women, ensuring a commitment to high-quality care for those on the path to recovery. If you or someone close to you is in search of thorough substance use treatment within a nurturing and supportive atmosphere, this center could be an excellent option for your healing process.

CleanSlate Centers
Waukesha, WI

CleanSlate Centers, located in Waukesha, WI, specializes in outpatient treatment for substance use, emphasizing personalized care for adults and young adults. The facility offers outpatient services for methadone/buprenorphine and naltrexone, catering to both men and women. By employing motivational interviewing, strategies for preventing relapse, and counseling for substance use disorders, the center customizes its treatment plans to address the specific needs of each client. With a strong dedication to high-quality care, CleanSlate Centers distinguishes itself through its targeted approach and extensive services designed to assist individuals in their recovery journey.

CleanSlate Centers
Scranton, PA

CleanSlate Centers located in Scranton, PA, specializes in outpatient treatment for substance use, utilizing therapies such as methadone, buprenorphine, and naltrexone. The center adopts motivational interviewing techniques, relapse prevention methods, and counseling for substance use disorders to assist clients. They prioritize a tailored approach, serving both adults and young adults across all genders. CleanSlate Centers in Scranton fosters a secure and welcoming atmosphere for individuals pursuing addiction recovery, committing to high-quality care and customized assistance during each step of the healing process.

CleanSlate Centers
Anderson, IN

Located in Anderson, IN, CleanSlate Centers provides outpatient services for those dealing with substance use issues, emphasizing personalized care for both adults and young adults. The center specializes in outpatient treatment options such as methadone, buprenorphine, and naltrexone, and employs techniques like motivational interviewing, relapse prevention strategies, and comprehensive counseling for substance use disorders. CleanSlate Centers is dedicated to crafting individualized plans for each patient, welcoming both men and women who are seeking effective addiction recovery solutions. By focusing on tailored treatment and proven therapeutic methods, this facility creates a nurturing space for individuals working towards their recovery journey.

CleanSlate Centers
Leominster, MA

CleanSlate Centers located in Leominster, MA, specializes in outpatient treatment for substance use disorders, offering methadone, buprenorphine, and naltrexone therapies. The center prioritizes motivational interviewing, strategies for preventing relapse, and counseling specifically for substance use issues. It provides customized treatment plans for both adults and young adults, addressing the needs of male and female clients alike. CleanSlate Centers is dedicated to a personalized care strategy, ensuring that patients receive top-notch treatment from skilled professionals within a nurturing atmosphere. For those in need of effective addiction recovery solutions, CleanSlate Centers in Leominster is an excellent option to support your healing process.

CleanSlate Centers
Greenwood, IN

CleanSlate Centers, located in Greenwood, IN, specializes in outpatient treatment for substance use disorders, offering options such as methadone, buprenorphine, or naltrexone. The center employs techniques like motivational interviewing and focuses on relapse prevention along with counseling for substance use issues. Emphasizing tailored care, CleanSlate Centers serves adults and young adults across all genders. The facility is committed to delivering high-quality, evidence-based treatments aimed at helping individuals on their recovery journey. For those in need of thorough addiction treatment within a nurturing environment, this center provides customized programs designed to support long-term sobriety.

Placeholder image
Lexington, KY

CleanSlate Centers, located in Lexington, KY, is dedicated to providing outpatient treatment for substance use disorders, emphasizing personalized care. The center offers options such as methadone, buprenorphine, or naltrexone for adults and young adults, regardless of gender. By employing techniques like motivational interviewing and relapse prevention, along with counseling for substance use issues, the center aims to deliver thorough support on the path to recovery. Committed to customized treatment plans and a holistic perspective, CleanSlate Centers strives to offer exceptional care for those wishing to break free from addiction. For those seeking individualized assistance in a nurturing atmosphere, this facility is focused on promoting sustainable sobriety.

Placeholder image
Noblesville, IN

CleanSlate Centers, located in Noblesville, IN, specializes in outpatient treatment programs for substance abuse, concentrating on customized care. The center offers outpatient services with methadone, buprenorphine, or naltrexone for adults and young adults across all gender identities. By employing techniques such as motivational interviewing, strategies for preventing relapse, and counseling for substance use disorders, this facility creates personalized treatment plans to address the unique requirements of each client. Committed to delivering high-quality care, CleanSlate Centers in Noblesville distinguishes itself through its individualized approach to recovery, ensuring everyone receives the necessary support for achieving sustainable sobriety.

Placeholder image
Philadelphia, PA

CleanSlate Centers, located in Philadelphia, PA, specializes in outpatient programs for substance use treatment designed for both adults and young adults of all genders. The center administers outpatient treatments with methadone, buprenorphine, or naltrexone, utilizing proven methods like motivational interviewing, relapse prevention, and counseling for substance use disorders. Emphasizing personalized care, CleanSlate Centers is committed to addressing the distinct needs of each individual to facilitate effective treatment. Patients can look forward to receiving exceptional, empathetic support from a team of skilled professionals focused on guiding individuals toward recovery.

Placeholder image

CleanSlate Centers in Wareham, MA, delivers outpatient care for addiction, centering on customized treatment plans for adults and young adults. This location offers personalized methadone/buprenorphine or naltrexone treatment. The program incorporates motivational techniques, relapse prevention methods, and addiction counseling to aid individuals in their recovery. By focusing on individual requirements, CleanSlate Centers provides a thorough treatment experience. This facility welcomes both male and female patients seeking high-quality, individualized assistance.

Placeholder image
Milwaukee, WI

CleanSlate Centers in Milwaukee, WI, delivers community-based addiction treatment tailored to each individual's requirements. They specialize in outpatient programs for adults and young adults, incorporating medication-assisted treatment with options like methadone, buprenorphine, or naltrexone. Their therapeutic methods include motivational interviewing, relapse prevention techniques, and comprehensive counseling for substance use disorders. CleanSlate Centers in Milwaukee is committed to offering a personalized, evidence-based path to recovery for all clients.

Frequently Asked Questions

What is buprenorphine and how does it treat opioid addiction?
Buprenorphine is a partial opioid agonist medication approved by the FDA for treating opioid use disorder. It binds to the same receptors as heroin and fentanyl but produces a much weaker effect, reducing cravings and withdrawal symptoms without causing intense euphoria. Buprenorphine has a ceiling effect, meaning its opioid effects plateau at moderate doses, making it safer than methadone in terms of overdose risk.
What is the difference between Suboxone and Subutex?
Suboxone contains two active ingredients — buprenorphine and naloxone — while Subutex contains only buprenorphine without naloxone. The naloxone in Suboxone is included as an abuse deterrent; it remains inactive when taken sublingually as prescribed but triggers withdrawal if the medication is injected. Subutex is generally reserved for patients who cannot tolerate naloxone, such as pregnant women.
What is a Sublocade injection and how does it work?
Sublocade is a once-monthly injectable form of buprenorphine administered as a subcutaneous injection in the abdominal area. After injection, the medication forms a solid deposit under the skin that slowly releases buprenorphine over the course of a month. This eliminates daily dosing and removes the possibility of missed doses or medication diversion.
What are the common side effects of Suboxone?
Common Suboxone side effects include headache, nausea, constipation, insomnia, sweating, and mouth numbness or pain from sublingual administration. Some patients also experience dizziness, drowsiness, and blurred vision, particularly when starting treatment. Most side effects diminish within the first few weeks as the body adjusts. Patients should report difficulty breathing or signs of allergic reaction immediately.
What happens during Suboxone withdrawal?
Suboxone withdrawal occurs when a patient stops taking the medication abruptly after prolonged use, with symptoms including muscle aches, anxiety, insomnia, nausea, and irritability. A medically supervised taper is strongly recommended, typically reducing the dose by small increments over weeks or months. The risk of opioid relapse is significantly higher during unsupervised discontinuation.
How does Suboxone compare to methadone?
Suboxone and methadone are both effective for opioid use disorder but differ in key ways. Methadone is a full opioid agonist dispensed daily at licensed clinics, while Suboxone is a partial agonist that can be prescribed by qualified physicians and taken at home. Suboxone carries a lower overdose risk due to its ceiling effect and offers greater convenience, though methadone may be more appropriate for patients with severe, long-standing dependence.
How can I find a Suboxone clinic or doctor near me?
The most reliable way to find a Suboxone provider is through SAMHSA's online treatment locator at findtreatment.gov, which allows you to search by location and filter for buprenorphine providers. Many primary care offices, addiction treatment centers, and telehealth platforms now offer Suboxone prescriptions following the elimination of the federal X-waiver requirement in early 2023.
What is Zubsolv and how is it different from Suboxone?
Zubsolv is a brand-name buprenorphine and naloxone sublingual tablet that features a mint flavor and dissolves faster under the tongue than other options. Due to its higher bioavailability, Zubsolv uses different dosing strengths — a Zubsolv 5.7 mg/1.4 mg tablet is considered equivalent to a Suboxone 8 mg/2 mg dose. Patients switching between products should work closely with their prescriber for correct dose conversion.
Does Medicaid cover Suboxone treatment?
Yes — Medicaid covers buprenorphine (including Suboxone, Sublocade, Subutex, Zubsolv, and Brixadi) for opioid use disorder in all 50 states, as required by the SUPPORT Act of 2018. Medicaid is the largest single payer for MAT in the US. Coverage details vary by state — some require prior authorization or limit certain formulations. Many OBOT clinics accept Medicaid directly; telehealth Suboxone providers also bill Medicaid in most states. Bring your Medicaid card to your intake appointment.
Can I get Suboxone through telehealth?
Yes. After the MAT Act of 2023 permanently eliminated the X-waiver requirement, any licensed prescriber can prescribe Suboxone via telehealth in most states. The DEA also extended COVID-era telehealth flexibilities through at least 2025, allowing virtual Suboxone induction without a prior in-person visit. Several specialty platforms — Bicycle Health, Ophelia, Workit Health, Boulder Care — offer Medicaid-accepting telehealth Suboxone treatment. Telehealth has dramatically expanded access in rural and underserved areas with no nearby OBOT physicians.

About Buprenorphine (Suboxone)

Buprenorphine is classified as a partial opioid agonist, meaning it activates opioid receptors in the brain but to a much lesser degree than full agonists such as heroin, fentanyl, or oxycodone. This partial activation suppresses withdrawal symptoms and reduces cravings without producing dangerous respiratory depression or intense euphoria. Buprenorphine also has an unusually high binding affinity for the mu-opioid receptor, effectively blocking other opioids from attaching — providing a protective effect against relapse-related overdose.

How Buprenorphine Works

One of the defining features of buprenorphine is its ceiling effect — after a certain dose threshold, increasing the amount does not produce additional opioid effects. This dramatically reduces the risk of fatal overdose compared to methadone or illicit opioids. The ceiling effect, combined with its long duration of action (24 to 72 hours), makes buprenorphine one of the safest and most effective tools in medication-assisted treatment (MAT). Approved by the FDA in 2002, buprenorphine was a breakthrough because it could be prescribed in outpatient settings rather than requiring daily clinic visits.

Buprenorphine Brand Comparison: Suboxone, Subutex, Sublocade, Zubsolv, Brixadi

Buprenorphine is available under several FDA-approved brand names, each with distinct formulations, dosing schedules, and clinical use cases. The comparison below highlights the key differences:

BrandActive ingredientFormFrequencySettingFDA yearBest for
SuboxoneBuprenorphine + naloxoneSublingual film / tabletDailyOBOT, telehealth, retail pharmacy2002Most prescribed; naloxone deters injection misuse
SubutexBuprenorphine (alone)Sublingual tabletDailyOBOT2002Pregnancy; documented naloxone sensitivity
SublocadeBuprenorphine extended-releaseSubcutaneous injection (ATRIGEL depot)MonthlyClinic-administered2017No daily dosing; eliminates diversion risk
ZubsolvBuprenorphine + naloxoneSublingual tablet (higher bioavailability)DailyOBOT2013Faster dissolution; mint flavor; lower mg/dose
BrixadiBuprenorphine extended-releaseSubcutaneous injectionWeekly or monthlyClinic2023Newer alternative to Sublocade; weekly option for induction

All five medications are Schedule III controlled substances and equivalent in clinical efficacy at appropriate doses. The choice depends on adherence patterns, lifestyle, insurance coverage, and clinical context (e.g., pregnancy, prior injection use, daily-dosing burden). Many patients begin on sublingual Suboxone for stabilization and transition to monthly Sublocade or weekly Brixadi after sustained recovery.

Buprenorphine Side Effects

Common buprenorphine side effects include:

  • Headache and dizziness
  • Nausea and vomiting, especially during induction
  • Constipation and insomnia
  • Excessive sweating
  • Mouth numbness or oral discomfort from sublingual formulations

More serious side effects may include respiratory depression (particularly when combined with benzodiazepines or alcohol), liver problems, and allergic reactions. For most patients, side effects are mild and resolve within one to two weeks. The benefits in preventing relapse and overdose death significantly outweigh the risks.

Buprenorphine Dosage and Induction

Treatment begins with an induction phase where the patient must be in mild to moderate opioid withdrawal. Common induction doses range from 2 mg to 8 mg on the first day, with increases over the following days. Most patients stabilize on 8 mg to 24 mg per day, with 16 mg being the most commonly prescribed dose. Research suggests doses of 16 mg or higher are associated with better retention and outcomes. Dosage should always be adjusted under medical supervision.

Buprenorphine/Naloxone Combination

Many buprenorphine formulations include naloxone as an abuse deterrent. When taken sublingually as directed, naloxone has very low bioavailability and produces no clinical effect. However, if someone attempts to inject the medication, the naloxone component becomes fully active and triggers severe withdrawal. This design discourages injection misuse while having no impact on patients who take the medication correctly. The combination is the standard first-line formulation for opioid addiction treatment.

Suboxone: Sublingual Buprenorphine

Suboxone is the most recognized brand name for buprenorphine-naloxone and is most commonly dispensed as a sublingual film (Suboxone strips) that dissolves under the tongue. Suboxone has transformed opioid treatment by enabling millions of patients to receive effective pharmacotherapy in outpatient settings without the daily clinic visits required by methadone programs.

Suboxone Side Effects

Commonly reported Suboxone side effects include headache, nausea, tongue or mouth irritation, constipation, insomnia, sweating, and decreased libido. The sublingual film can cause irritation or small sores inside the mouth — rotating placement between under the tongue and against the cheek helps minimize this. Patients should not eat, drink, or smoke while the film is dissolving.

Suboxone Strips: Film vs. Tablet

Suboxone strips (sublingual film) have largely replaced the original tablet form. The film dissolves more quickly (two to four minutes), provides more consistent absorption, and is harder to divert due to individual foil packaging. Generic buprenorphine-naloxone tablets are often less expensive and may be preferred for cost reasons. Both are therapeutically equivalent when taken as prescribed.

Suboxone Treatment Programs

Comprehensive Suboxone treatment typically includes three phases:

  • Induction: Initial dosing under medical supervision, requiring the patient to be in early withdrawal
  • Stabilization: Dose adjustment until cravings and withdrawal are minimal, usually one to two months
  • Maintenance: Stable dosing for an extended period — often a year or longer — combined with counseling and behavioral therapy

Evidence consistently shows that longer treatment durations are associated with better outcomes. Most addiction medicine experts recommend a minimum of one to two years of maintenance therapy.

Find a Suboxone Clinic Near You — OBOT & Telehealth Options

Finding a Suboxone clinic has become significantly easier since the federal government eliminated the X-waiver requirement in January 2023, meaning any provider with a standard DEA license can now prescribe Suboxone. Patients can search SAMHSA's treatment locator at findtreatment.gov or use our directory to locate nearby facilities that offer buprenorphine-based treatment.

Suboxone Doctors Near Me

Beyond SAMHSA's locator, many state health departments maintain directories of addiction treatment providers. Telehealth has dramatically expanded access — several platforms now offer virtual Suboxone consultations, which is especially valuable for patients in rural areas. When selecting a provider, look for those offering comprehensive treatment including counseling, not just medication prescriptions.

Suboxone Withdrawal and Tapering

Suboxone withdrawal can include muscle aches, anxiety, insomnia, nausea, sweating, and intense opioid cravings. A gradual, medically supervised taper is recommended — typically reducing the dose by 10 to 25 percent every one to four weeks. Slower tapers over several months produce fewer symptoms and lower relapse rates. There is no medically mandated time limit for Suboxone treatment, and many patients benefit from indefinite maintenance.

Suboxone vs Methadone

Suboxone can be prescribed in office settings and taken at home, carries lower overdose risk due to its ceiling effect, and offers greater scheduling flexibility. Methadone is a full agonist that may be more effective for severe, long-standing dependence but must be dispensed at licensed clinics with daily visits. Neither is inherently superior — the best choice keeps the patient in treatment. Some patients may also benefit from naltrexone, a non-opioid alternative.

Sublocade: Monthly Buprenorphine Injection

Sublocade delivers buprenorphine as a once-monthly subcutaneous injection in the abdominal area using the ATRIGEL delivery system, which forms a solid biodegradable depot that slowly releases medication. Patients must first stabilize on sublingual buprenorphine (8 mg+ daily) for at least seven days. Treatment typically begins with two 300 mg injections, followed by maintenance on 300 mg or 100 mg. Sublocade eliminates concerns about daily adherence, missed doses, and medication diversion.

Sublocade Side Effects

The most common Sublocade side effects are injection-site reactions (pain, itching, redness, or a noticeable lump), nausea, constipation, headache, and fatigue. The injection-site lump is normal and gradually diminishes as medication is absorbed. Patients should avoid rubbing or massaging the site. Elevated liver enzymes may also occur but are usually mild and transient.

Subutex: Buprenorphine Without Naloxone

Subutex was the original brand-name buprenorphine product. While the brand has been discontinued, generic buprenorphine-only tablets remain available. Buprenorphine monotherapy is typically reserved for pregnant patients (to avoid naloxone exposure to the fetus), patients with documented naloxone sensitivity, or sometimes during the induction phase before transitioning to the combination product.

Subutex vs Suboxone

The primary difference is the absence of naloxone in Subutex. Because Subutex lacks the abuse-deterrent naloxone component, it may carry slightly higher diversion risk, and many insurance formularies prioritize the combination as the default. Current clinical guidelines favor buprenorphine-only formulations primarily for pregnancy and naloxone sensitivity.

Zubsolv: Alternative Buprenorphine Brand

Zubsolv is a buprenorphine-naloxone sublingual tablet featuring a mint flavor and faster dissolution (under two minutes). Due to enhanced bioavailability, Zubsolv uses different dose strengths — a 5.7 mg/1.4 mg tablet equals a Suboxone 8 mg/2 mg dose. Zubsolv is available in multiple strengths for flexible dosing during both induction and maintenance.

Buprenorphine resources:

Find Buprenorphine (Suboxone) by State

Browse buprenorphine (suboxone) programs in states with the most treatment options.

Explore Related Options

Related conditions, treatment approaches, and levels of care.

Medically Reviewed Updated July 2026

Reviewed by licensed addiction specialists. Information reflects current clinical guidance.

Sources:SAMHSA·NIDA·CDC

Need immediate help? Call SAMHSA: 1-800-662-4357 (24/7, free)